000 | 01484 a2200445 4500 | ||
---|---|---|---|
005 | 20250517152550.0 | ||
264 | 0 | _c20180326 | |
008 | 201803s 0 0 eng d | ||
022 | _a1432-2072 | ||
024 | 7 |
_a10.1007/s00213-017-4634-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSakurai, Hitoshi | |
245 | 0 | 0 |
_aPredicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. _h[electronic resource] |
260 |
_bPsychopharmacology _cAug 2017 |
||
300 |
_a2453-2461 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aCitalopram _xtherapeutic use |
650 | 0 | 4 |
_aDepressive Disorder, Major _xdiagnosis |
650 | 0 | 4 |
_aDisorders of Excessive Somnolence _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOutpatients |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 |
_aPsychomotor Agitation _xdiagnosis |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSelf Report |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSuzuki, Takefumi | |
700 | 1 | _aYoshimura, Kimio | |
700 | 1 | _aMimura, Masaru | |
700 | 1 | _aUchida, Hiroyuki | |
773 | 0 |
_tPsychopharmacology _gvol. 234 _gno. 16 _gp. 2453-2461 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-017-4634-5 _zAvailable from publisher's website |
999 |
_c27140197 _d27140197 |